OBJECTIVE To identify and define clinically meaningful type 1 diabetes outcomes beyond
hemoglobin A1c (HbA1c) based upon a review of the evidence, consensus from clinical …

Cardiovascular autonomic neuropathy (CAN) is a severely debilitating yet underdiagnosed
condition in patients with diabetes. The prevalence can range from 2.5%(based on the …

(CVD) in individuals with type 1 diabetes mellitus (T1DM), the pathophysiology underlying
the relationship between cardiovascular events, CVD risk factors, and T1DM is not well …

Preceding the joint meeting of the 19th annual Diabetic Neuropathy Study Group of the
European Association for the Study of Diabetes (NEURODIAB) and the 8th International …

Abstract The Cardiovascular Autonomic Neuropathy (CAN) Subcommittee of the Toronto
Consensus Panel on Diabetic Neuropathy worked to update CAN guidelines, with regard to …

Diabetic neuropathies (DNs) differ in clinical course, distribution, fiber involvement (type and
size), and pathophysiology, the most typical type being a length-dependent distal symmetric …

Cardiac autonomic neuropathy (CAN) is an often overlooked and common complication of
diabetes mellitus. CAN is associated with increased cardiovascular morbidity and mortality …

Diabetic peripheral and autonomic neuropathies are common complications of diabetes with
broad spectrums of clinical manifestations and high morbidity. Studies using various agents …

Physical therapists commonly treat people with diabetes for a wide variety of diabetes-
associated impairments, including those from diabetes-related vascular disease. Diabetes is …

Background Other than glycemic control, there are no treatments for diabetic neuropathy.
Thus, identifying potentially modifiable risk factors for neuropathy is crucial. We studied risk …